Braidwell »

Helix Acquisition Corp Iii shares owned by Braidwell

Quarter-by-quarter ownership of Helix Acquisition Corp Iii shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Helix Acquisition Corp Iii

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Iii held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Iii by Braidwell

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.3M 900k 10.30

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals (XENE)
Dianthus Therapeutics (DNTH)
Edgewise Therapeutics (EWTX)
Irhythm Technologies (IRTC)
Nuvalent Inc-a (NUVL)
Kodiak Sciences (KOD)
Cg Oncology (CGON)
Alphatec Hldgs Note 0.750% 3/1 (Principal)

View all positions for Braidwell

Top funds holding Helix Acquisition Corp Iii

Cormorant Asset Management
RA Capital Management
Nantahala Capital Management
ADAR1 Capital Management
Balyasny Asset Management
Braidwell
Toronto-Dominion Bank
Millennium Management
OZ Management
Commodore Capital
Sona Asset Management
Stempoint Capital
Two Sigma Investments
Longaeva Partners
Berkley W R

View all funds holding Helix Acquisition Corp Iii